There's no one best treatment for Crohn's disease. So your doctor will try to find what works best to stop your symptoms and keep the disease from damaging your body. To create your treatment plan ...

The drug is already approved in the EU to treat ulcerative colitis, another form of inflammatory bowel disease ...

Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of ...

Children with Crohn’s disease are at higher risk of developing perianal fistulas ... These deleterious effects often occur in children and are difficult to treat. Therefore, early treatment or ...

22, 2024 — A large-scale clinical trial of treatment strategies for Crohn's disease ... and children ... Developing a Less Invasive Test for Inflammatory Bowel Disease Sep.

A recent study reveals that anti-TNF drugs significantly reduce the risk of anal fistulas in children with Crohn's disease.

Infliximab biosimilar is under clinical development by Celltrion and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

The resulting paper, "Early tumour necrosis factor antagonist treatment prevents perianal fistula development in children with Crohn's disease: Post-hoc analysis of the RISK study," appeared in Gut.

A new study published recently in the journal Gut shows children with Crohn's who were prescribed anti-TNF (tumor necrosis ...

Remestemcel-L is under clinical development by Mesoblast and currently in Phase III for Crohn's Disease (Regional Enteritis).